12 Month Price Forecast For GOCO
Distance to GOCO Price Forecasts
GOCO Price Momentum
🤔 Considering GoHealth (GOCO)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 23, 2025 7:40 AM UTC
GOCO Analyst Ratings & Price Targets
Based on our analysis of 10 Wall Street analysts, GOCO has a consensus that is bullish. The median price target is $20.00, with forecasts ranging from $13.00 to $25.00. Currently, there are 3 Buy ratings, 1 Hold ratings, and 0 Sell ratings.
With GOCO currently trading at $15.00, the median price forecast suggests a 33.3% upside. The most optimistic forecast comes from at , projecting a 66.7% upside, while Ben Hendrix at RBC Capital provides the most conservative target, suggesting a -13.3% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
GOCO Analyst Consensus
GOCO Price Target Range
Latest GOCO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for GOCO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Oct 21, 2024 | RBC Capital | Ben Hendrix | Sector Perform | Reiterates | $13.00 |
| Mar 20, 2024 | RBC Capital | Ben Hendrix | Sector Perform | Maintains | $13.00 |
| Apr 4, 2023 | Credit Suisse | Jonathan Yong | Underperform | Maintains | $8.50 |
| Mar 17, 2023 | RBC Capital | Ben Hendrix | Sector Perform | Maintains | $14.00 |
| Aug 26, 2022 | RBC Capital | Ben Hendrix | Sector Perform | Maintains | $1.00 |
| Aug 16, 2022 | Credit Suisse | Jonathan Yong | Underperform | Maintains | $1.25 |
| Mar 16, 2022 | Evercore ISI Group | Elizabeth Anderson | In-Line | Maintains | $1.75 |
| Mar 16, 2022 | Morgan Stanley | Lauren Schenk | Equal-Weight | Maintains | $1.00 |
| Mar 3, 2022 | RBC Capital | Frank Morgan | Sector Perform | Downgrade | $2.00 |
| Mar 2, 2022 | Truist Securities | Hold | Downgrade | $0.00 | |
| Jan 7, 2022 | Credit Suisse | Jailendra Singh | Underperform | Downgrade | $3.00 |
| Jan 5, 2022 | B of A Securities | Michael Cherny | Underperform | Downgrade | $3.50 |
| Nov 15, 2021 | Credit Suisse | Jailendra Singh | Neutral | Maintains | $6.00 |
| Nov 11, 2021 | Morgan Stanley | Equal-Weight | Maintains | $5.50 | |
| Nov 10, 2021 | Barclays | Steve Valiquette | Equal-Weight | Downgrade | $5.00 |
| Nov 10, 2021 | RBC Capital | Frank Morgan | Outperform | Maintains | $10.00 |
| Nov 9, 2021 | Barclays | Equal-Weight | Downgrade | $0.00 | |
| Aug 13, 2021 | Barclays | Steve Valiquette | Overweight | Maintains | $10.00 |
| Aug 12, 2021 | Morgan Stanley | Lauren Schenk | Equal-Weight | Maintains | $13.00 |
| Aug 12, 2021 | Evercore ISI Group | In-Line | Downgrade | $0.00 |
Stocks Similar to GoHealth Inc
The following stocks are similar to GoHealth based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
GoHealth Inc (GOCO) Financial Data
GoHealth Inc has a market capitalization of $316.90M with a P/E ratio of -2.1x. The company generates $686.46M in trailing twelve-month revenue with a -4.3% profit margin.
Revenue growth is -10.4% quarter-over-quarter, while maintaining an operating margin of -35.3% and return on equity of -15.9%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
GoHealth Inc (GOCO) Company Overview
About GoHealth Inc
Health insurance marketplace specializing in Medicare plans.
The company operates a technology platform that uses machine-learning algorithms to match individuals with suitable health insurance plans, primarily focusing on Medicare products. It generates revenue by selling Medicare Advantage, Supplement, and Prescription Drug plans through various channels, including carriers, online platforms, and independent agencies.
Founded in 2001 and headquartered in Chicago, GoHealth leverages data to optimize the insurance selection process, making it easier for customers to find plans that meet their specific needs.
Company Information
Sector
Financial Services
Industry
Insurance Brokers
Employees
2,530
CEO
Mr. Vijay Kumar Kotte
Country
United States
IPO Year
2020
Website
www.gohealth.comGoHealth Inc (GOCO) Latest News & Analysis
GoHealth: Smart Moves Are Paying Off
2 months agoGoHealth Inc reported positive operating cash flow over the past year, acquired e-TeleQuote in Q3 2024, and refinanced its debt, enhancing income and cash flow potential.
GoHealth's positive cash flow, strategic acquisition, and favorable debt refinancing indicate financial stability and growth potential, enhancing its attractiveness to investors.
GoHealth, Inc. (NASDAQ:GOCO) will hold its Q3 2024 Earnings Conference Call on November 7, 2024, at 8:00 AM ET, featuring company executives and financial analysts.
GoHealth's Q3 earnings call provides insights into its financial performance and strategic direction, influencing investor sentiment and stock valuation.
GoHealth Reports Third Quarter 2024 Results
2 months agoGoHealth, Inc. (NASDAQ: GOCO) reported its financial results for Q3 and the first nine months of 2024, focusing on its position in the health insurance and Medicare markets.
GoHealth's financial results can indicate its market performance and growth potential, impacting stock value and investment decisions in the health insurance sector.
GoHealth (GOCO) reported a quarterly loss of $3.73 per share, exceeding the Zacks Consensus Estimate of a $3.19 loss, and worsening from a loss of $2.61 per share a year earlier.
GoHealth's larger-than-expected quarterly loss signals worsening financial health, potentially impacting stock valuation and investor confidence.
GoHealth to Present and Host Investor Meetings at the LD Micro Main Event XVII on October 29th in Los Angeles, CA
3 months agoGoHealth Inc. (NASDAQ: GOCO) CEO Vijay Kotte will present at the LD Micro Main Event on October 29, 2024, at 3:00 pm CT. The event will be webcast for investors.
GoHealth's CEO presentation at a major investor conference signals potential insights into company performance and future strategies, which could influence stock valuation and investor sentiment.
GoHealth has appointed Brendan Shanahan as Chief Financial Officer. Shanahan brings over 30 years of financial leadership experience to the role.
Brendan Shanahan's appointment as CFO signals strong financial leadership, potentially enhancing GoHealth's strategic direction and stability, which can positively impact investor confidence and stock performance.
Frequently Asked Questions About GOCO Stock
What is GoHealth Inc's (GOCO) stock forecast for 2025?
Based on our analysis of 10 Wall Street analysts, GoHealth Inc (GOCO) has a median price target of $20.00. The highest price target is $25.00 and the lowest is $13.00.
Is GOCO stock a good investment in 2025?
According to current analyst ratings, GOCO has 3 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $15.00. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for GOCO stock?
Wall Street analysts predict GOCO stock could reach $20.00 in the next 12 months. This represents a 33.3% increase from the current price of $15.00. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is GoHealth Inc's business model?
The company operates a technology platform that uses machine-learning algorithms to match individuals with suitable health insurance plans, primarily focusing on Medicare products. It generates revenue by selling Medicare Advantage, Supplement, and Prescription Drug plans through various channels, including carriers, online platforms, and independent agencies.
What is the highest forecasted price for GOCO GoHealth Inc?
The highest price target for GOCO is $25.00 from at , which represents a 66.7% increase from the current price of $15.00.
What is the lowest forecasted price for GOCO GoHealth Inc?
The lowest price target for GOCO is $13.00 from Ben Hendrix at RBC Capital, which represents a -13.3% decrease from the current price of $15.00.
What is the overall GOCO consensus from analysts for GoHealth Inc?
The overall analyst consensus for GOCO is bullish. Out of 10 Wall Street analysts, 3 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $20.00.
How accurate are GOCO stock price projections?
Stock price projections, including those for GoHealth Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
